Experimental Drug Doubles Survival Time for Pancreatic Cancer Patients
A groundbreaking experimental drug has shown potential in doubling survival time for patients with pancreatic cancer. This development is being hailed as a significant breakthrough against one of the deadliest forms of cancer.